Breakthrough T1D Clinical & Research Congress · 2026
A structured decision-provenance architecture built to represent the human reasoning, uncertainty, context and timing that conventional clinical telemetry leaves out.
Presented by Mark E. Paull at CRC 2026 in Philadelphia: one short oral presentation and two e-posters, all accepted through competitive abstract review. This site is the public, conference-safe presentation layer. Reconstructive engineering detail remains private.
Mark E. PaullIndependent Researcher · Decision Systems Architect · 60th year with type 1 diabetesOne subject, 68 consecutive days — 12 October to 18 December 2025, no gaps. Proof of concept, not validation.
Verified post-submission dataset figures are 340 structured variables across 68 consecutive days. Conference-submission details that remain under CRC embargo are withheld until October 9, 2026.
CRC 2026 · THREE ACCEPTED PRESENTATIONS
EXPLORE THE THREE CRC 2026 PRESENTATIONS1 ORAL · 2 E-POSTERS · ACCEPTED THROUGH COMPETITIVE ABSTRACT REVIEW
BREAKTHROUGH T1D CLINICAL & RESEARCH CONGRESS · PHILADELPHIA · OCTOBER 9–11, 2026
Three accepted presentations. Conference files will be released when CRC 2026 opens on October 9; the peer-reviewed #47 paper is already public.
Temporal Topology in Continuous Glucose Monitoring
Published result — Diabetes Technology & Therapeutics
An 89-day CGM series of 25,536 readings: circular temporal topology preserved 12.1% more information than midnight segmentation (3.56 vs 3.18 bits, p < 0.001).
This is the peer-reviewed temporal-topology study, a separate dataset from the ESP360° annotated workbook of 68 consecutive days shown above. PubMed
Conference abstract details available October 9, 2026
Accepted e-poster.
Abstract content remains under CRC publication embargo until October 9, 2026.
Conference abstract details available October 9, 2026
Accepted e-poster.
Abstract content remains under CRC publication embargo until October 9, 2026.
ESP360° CONFERENCE SITE
Direct access to CRC 2026 presentation information, public research material and release status. Embargoed conference files unlock October 9.
Tap the button to install ESP360° on this device.
The longitudinal record begins before digital diabetes
A Canadian Diabetes Association newsletter clipping documents the beginning of the lived record behind the later ESP360° architecture. The research argument is not that longevity proves the model; it explains the unusually long observational substrate from which the decision-layer problem emerged.
See the research lineage →Choose your depth
The front page stays simple. The deeper material is separated by audience so the site does not try to say everything at once.
What ESP360° means without technical vocabulary, and why a glucose number is not the same thing as the decision that produced it.
What the architecture adds to CGM, insulin and outcome review without replacing clinical judgment or making autonomous recommendations.
Study scope, record structure, variable classification, verification status and the limits of what a single-subject dataset can establish.
The six architectural domains, where decision provenance sits beside existing telemetry, and what is deliberately withheld.
The core distinction
A model may infer why a person acted. ESP360° is designed to preserve what the person actually knew, expected, feared, weighed and decided before the outcome was known.
